Literature DB >> 9813036

Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor.

A Shinkai1, M Ito, H Anazawa, S Yamaguchi, K Shitara, M Shibuya.   

Abstract

The kinase insert domain-containing receptor (KDR) for vascular endothelial growth factor (VEGF) has been shown to be involved in vasculogenesis and angiogenesis. This receptor is characterized by seven immunoglobulin (Ig)-like domains within its extracellular region. To identify the domains involved in VEGF binding, we constructed various deletion mutants of the extracellular region fused with the crystallizable fragment portion of an IgG and then examined the binding affinity with VEGF by means of the BIAcore biosensor assay. Deletion of the COOH-terminal two or three Ig-like domains out of a total of seven affected ligand dissociation rather than association. Further deletion of the fourth domain caused a drastic decrease in the association rate. Binding ability was abolished completely with removal of the third domain. The mutant KDR proteins lacking the NH2-terminal Ig-like domain exhibited a slightly higher association rate compared with those of the mutants having this domain. Deletion of the first two NH2-terminal Ig-like domains caused a drastic reduction in the association rate, but affinity to VEGF was retained. These results suggest that the third Ig-like domain is critical for ligand binding, the second and fourth domains are important for ligand association, and the fifth and sixth domains are required for retention of the ligand bound to the receptor molecule. The first Ig-like domain may regulate the ligand binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813036     DOI: 10.1074/jbc.273.47.31283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Soluble vascular endothelial growth factor decoy receptor FP3 exerts potent antiangiogenic effects.

Authors:  De-Chao Yu; Jung-Sun Lee; Ji Young Yoo; Hyewon Shin; Hongxin Deng; Yuquan Wei; Chae-Ok Yun
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

4.  Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.

Authors:  Yong Cheng; Li Yuan; Ming-Wei Zhao; Tong Qian
Journal:  Int J Ophthalmol       Date:  2021-03-18       Impact factor: 1.779

Review 5.  Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.

Authors:  Caroline A C Hyde; Alexandra Giese; Edward Stuttfeld; Johan Abram Saliba; Denis Villemagne; Thomas Schleier; H Kaspar Binz; Kurt Ballmer-Hofer
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

6.  Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling.

Authors:  Yan Yang; Peng Xie; Yarden Opatowsky; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

7.  Piperine, a dietary phytochemical, inhibits angiogenesis.

Authors:  Carolyn D Doucette; Ashley L Hilchie; Robert Liwski; David W Hoskin
Journal:  J Nutr Biochem       Date:  2012-08-16       Impact factor: 6.048

8.  Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

Authors:  Ajithkumar Puthillath; Anush Patel; Marwan G Fakih
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

Review 9.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

Review 10.  Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells.

Authors:  Jean-Leon Thomas; Kasey Baker; Jinah Han; Charles Calvo; Harri Nurmi; Anne C Eichmann; Kari Alitalo
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.